POTASSIUM BALANCE
Dr. T. Dixon
Objectives
![]()
-To understand the mechanisms responsible for the maintenance of potassium homeostasis, its distribution between intra- and extra-cellular compartments.
-To learn about hormonal regulation of potassium homeostasis.
-To obtain a clear picture on the role of the nephron in maintaining potassium homeostasis
-To understand urinary tests designed to diagnose the disorderes of potassium homeostasis.
-To enable the diagnosis of causes of hypokalemia.
-To enable the dignostic workup of a patient with hyperkalemia and provide a pathophysiologically relevant therapy of this condition.
External and internal potassium balances are regulated to maintain an extracellular fluid (ECF) concentration of 3.5 to 5.5 mEq/L and a total body content of about 50 mEq/Kg (40 mEq/kg in females). A simplified daily balance sheet would show the following:
Input
|
Output
|
|
Dietary K+ 50-125 mEq |
Urine 45-112 mEq |
|
|
Feces 5-12 mEq |
|
|
|
A more detailed example that accounts for the distribution of potassium within the body is given in the following figure.
Balance usually is disrupted by increase
in renal, gastrointestinal, or skin losses which produce negative balance; or
decreases in renal excretion which produces a positive balance. Changes in body potassium content (>95%
in cells) are not necessarily reflected in plasma potassium concentration. Therefore, it is necessary to examine
factors that regulate internal balance by regulating the distribution of
potassium between the intracellular and extracellular fluids.

1. Factors Regulating Plasma Potassium
(Internal Balance)
a. Blood pH
Academia causes a shift of K+
from the intracellular space of cells into the plasma; whereas, alkalemia
causes a shift of K+ from the plasma into cells. These shifts result in a change in internal
potassium balance. A very rough guide
of the magnitude of this redistribution of potassium is that plasma K+
may rise about 0.6 mEq/L for each decrease in pH of 0.1 units.
This redistribution of potassium is
not solely dependent on the acidity since different types of acids result in
different magnitudes of potassium shifts.
Mineral acidosis (where the anion associated with the acidosis is
chloride, sulfate or phosphates) are usually associated with the degree of
shift described above. On the other
hand, shifts in the distribution of potassium usually do not result from
acidosis caused by nonmineral or organic acidosis (where the accompanying anion
is lactate, acetate, beta-hydroxybutyrate etc.).
The plasma bicarbonate concentration
seems to have an effect on the uptake of potassium by cells that is independent
of the pH of the blood. Under
conditions of constant blood pH, infusion of sodium bicarbonate leads to a
decrease in plasma potassium concentration.
b. Insulin
Insulin is the first-line defense
against hyperkalemia. A rise in plasma
K+ stimulates insulin release by the pancreatic beta cell. Insulin, in turn, enhances cellular
potassium uptake, returning plasma K+ towards normal. The enhanced cellular uptake of K+
that results from increased insulin levels is thought to be largely due to the
ability of insulin to stimulate activity of the sodium potassium ATPase located
in cell plasma membranes. The insulin
induced cellular uptake of potassium is not dependent on the uptake of glucose
caused by insulin. Insulin deficiency
allows a mild rise in plasma K+ chronically and makes the subject
liabel to severe hyperkalemia if a potassium load is given. Conversely, potassium deficiency may cause
decreased insulin release. Thus plasma
potassium and insulin participate in a feedback control mechanism.
c. Catecholamines
Catecholamines are also involved in
the regulation of the distribution of potassium as described in the following
table. Notice that beta-2-agonists
lower plasma potassium (by causing a cellular uptake of potassium) and alpha
agonists increase plasma potassium concentration..

d. Physical Conditioning and Exercise
Strenuous exertion may injure muscle
cells and allow leakage of K+ into the ECF. Highly trained athletes may have normal
total body K+ content, but redistributed K+ into muscles,
thus producing hypokalemia.
e. Activity of Cell Membrane Na-K ATPase
These ion pumps use ATP to fuel transport
of sodium from the cell to the ECF in exchange for the uptake of potassium by
the cell, and thus are an important menas of regulating the distribution of
potassium between intra and extracellular compartments. Some of the other regulators of internal
potassium balance such as insulin, physical training, catecholamines may exert
their effect by altering the activity of the sodium potassium ATPase in cell
membranes.
2. Factors Regulating Body Potassium Content
(External Balance)
a. Renal Excretion of K+
The Kidney can rapidly excrete large
loads of potassium, 200-300 mEq/day, with out a change in plasma K+
or body K+ content.
Potassium is filtered freely at the gomerulus but 90-95% is reabsorbed
in the proximal tubule. The major site
of renal regulation of potassium excretion occurs in the distal tubules and
collecting ducts where variations in the amount of potassium absorbed from or
secreted into the urine regulates potassium balance. In contrast to the ability to increase excretion rapidly to meet
increased input, the ability to reduce excretion to zero or very low levels is
slow, taking perhaps 2 to 4 weeks.
Thus, negative external balance due to sudden decreased in K+
intake or increases in gastrointestinal or skin losses will be furthered by a
continued leak of K+ into the urine until the condition is
chronic. The major determinants of
urinary potassium excretion include the following:
1)
Aldosterone
Aldosterone stimulates distal
nephron secretion of potassium. The
stimulation of secretion is related to the ability of aldosterone to stimulate
sodium potassium ATPase activity in cells of the distal tubule as well as its
ability to alter the apical (urinary) membrane conductance of potassium in
these cells. In the absence of
aldosterone, body potassium content and plasma K+ are increased due
to a decrease in renal excretion of potassium.
In the presence of excess aldosterone both total body K+ and
plasma K+ are decreased. An
increased plasma K+ stimulates aldosterone secretion and decreased
plasma K+ suppressed it.
2)
Urine Flow Rate
Increase urinary flow rate increases
urinary potassium excretion, presumable by maintaining chemical gradient for
potassium that favor the passive secretion of potassium from the cell into the
urinary filtration cells of the distal tubule.
3)
Urinary Sodum Concentration
Sodium delivery to distal nephron
may promote K+ excretion (Na-K exchange), but it is not certain if
this is independent of flow rate since in most instances increased urinary
sodium is accompanied by increased urinary flow rate.
4)
Non Reabsorbable Anions (Urinary Cl- Concentration)
Sulfates and others create favorable
electrical (lumen negative) gradients for passive secretion of potassium into
the urine. Additionally, the decreased
urinary chloride concentrations present under these circumstances contribute to
potassium excretion by inhibiting the reabsorption of potassium by the K-H
ATPase present in intercalated cells of the distal tubule.
5)
Plasma K+ Concentration
Changes in the peritubular plasma K+
concentration lead to changes in the rate of secretion of potassium by distal
tubular cells. Increased plasma K+
leads to an increased rate of secretion presumably due to an increased cellular
K+ concentration that creates a more favorable gradient for the
passive secretion of K+ into the urine. Decreased plasma K+ has the opposite effect.
6)
pH of the Blood
Acutely alkalosis leads to an
increase in the K+ concentration of the cells of the distal tubule,
this leads to a more favorable gradient that is associated with increased
urinary secretion of potassium. Acidosis
has the opposite effect. With chronic
changes in acid-base status, the relationship between changes in pH of the
blood and potassium excretion are more complex and the relationship found in
the actute state may be altered.
b. Gastrointestinal Potassium Excretion
Normally 10 – 15% of K+
intake is excreted by the gut.
Aldosterone is one of the regulators of secretion of potassium by the
gastrointestinal tract. Diarrhea
increased fecal K+ losses, particularly laxative-related
diarrhea. Diarrhea may contain 100
mEq/L of K+.
c. Skin Potassium Excretion
Normally only a trivial amount of K+
is excreted in perspiration. However,
working in hot temperatures may produce up to 10-12 liters of sweat per day
containing 10 mEq/L of K+.
Thus major K+ losses may occur via this route. Of interest, sweat K+ is also
under control of the hormone aldosterone.
3) POTASSIUM ADAPTATION
If an experimental animal is
maintained on a low or moderate potassium intake, a sudden increase in dietary
potassium, may result in severe hyperkalemia and the animal may die. However, if the low potassium diet is
gradually supplemented with additional potassium the same large potassium loads
which previously had produced dangerously high plasma potassium levels become
harmless. The animal has become adapted
to high potassium loads through the process of ingesting gradually increasing
amounts of potassium in its diet. The
physiologic components of the adaptation include the ability to excrete a
potassium load more quickly (renal potassium secretory rates are markedly
enhanced) and the temporary storage potassium in the intracellular fluid is
more effective. Thus, following a large
load of potassium, plasma potassium levels do not rise to the same degree in
the potassium adapted animal as they do in the nonadapted animal
The mechanism(s) responsible for
potassium adaptation are not well understood.
There is evidence that diets high in potassium result in increased
aldosterone secretion rates, increased insulin release, the induction of larger
amounts of Na K ATPase in the cells of the renal tubule and the large
intestine. It can be shown that the
potassium secretory capacity of the distal nephron (specifically the distal
half of the distal convoluted tubule and the cortical collecting tubule) is
markedly enhanced in animals on high potassium intake and this enhancement can
be shown to characterize the function of the isolated nephron segment in vitro
as well as in vivo.
HYPOKALEMIA
Hypolkalemia usually but not always
is a sign of potassium deficiency.
Internal shifts due to pH and other factors must be considered in
evaluating the change in potassium content.
A rough guide for the evaluation of K+ deficiency displayed
in the following figure which depicts total body potassium deficiency as a
function of serum potassium. Notice the
variability in the amount of total body K+ deficiency present for a
given serum K+ concentration.

Figure
2. Relationship of serum potassium concentration to body potassium deficit .
The data are derived from seven metabolic balance studies out on 24 subjects depleted
of potassium. (From RH Sterns et al. Medicine 60:339,1981)
1. Consequences of Hypokalemia/Potassium Deficiency
a. Metabolic Effects
Hypokalemia suppresses insulin
release leading to glucose intolerance.
Potassium deficiency in children retards growth.
Hypokalemia
causes intracellular acidosis and increased renal ammonia production. In the patients with encephalopathy due to
cirrhosis of the liver, hypokalemia may worsen the encephalopathy.
b. Cardiovascular Effects
Hypokalemia causes electrophysiologic
abnormalities that result in changes in the EKG depicted in the follow figure.

Figure
3. The EKG abnormalities associated with hypokaliemia include the following:
-decreases amplitude or inversion of
the T wave
-
increases
amplitude of the U wave
-
prolongation
of the Q-U interval
-
Increased
amplitude of the P wave, prolongation of the P-R interval
-
Wideving
of the QRS complex
Hypokalemia
enhances the development of atrial and ventricular arrhythmias in patients on
digits.
c. Neuromuscular Effects
Hypokalemia causes muscle weakness,
even paralysis. Muscle membranes may be
injured producing rhabdomyolysis. Ileus
of the gut may also occur.
The
neuromuscular and cardiovascular effects can partically be predicted based on
the electrophysiology depicted in the figure below. Changes in potassium exert their effect by altering resulting
membrane potential. This, as we shall
see, can be used to formulate therapy in hyperkalemia with calcium which alters
threshold potential.

d. Renal Effects
Hypokalemia causes both increased
thirst and a renal concentrating defect resulting in polyuria. Prolonged hypokalemia causes proteinuria,
proximal renal tubule vaculization, interstitial fibrosis and possibly
decreased renal blood flow and glomerular filtration rate. Hypokalemia stimulates acid secretion by the
kidney as well as production of the urinary buffer ammonia thus potentially
causing alkalinization of the blood.
2. Causes of Hypokalemia/Potassium Deficiency
The lack of a fixed relationship
between plasma K+ concentration and body K+ content
allows three groups of disorders.
a.
Hypokalemia without potassium deficit
b.
Hypokalemia with potassium deficit
c.
Potassium deficit without hypokalemia
The table provides a comprehensive
list of causes. This list is mildly
overwhelming. In order to sort through
this list, use the balance concept.
This will allow you to ask five basic questions. (Also, note the three * categories account
for greater than 90% of cases).
Hypokalemia without
potassium deficit
Respiratory alkalosis
Familial hypokalemic periodic paralysis
Athletes
Hypokalemia with potassium
deficit
Poor dietary intake
Tea and toast diet
Alcoholism
Anorexia nervosa
Geophagia
Cellular incorporation
Treatment of megaloblastic anemia
Intravenous hyperalimentation
Gastrointestinal loss
* Protracted vomiting
* Diarrhea
Laxative abuse
Ureterosigmoidoscopy
Obstructed or long ileal loop
Villous edema
Urinary Loss
Excess mineralocorticoid
effect
Primary or secondary hyperaldosteronism
Bartter’s syndrome
Excessive glucocorticoid hormones (Cushing’s syndrome)
Licorice abuse
Excessive ACTH
Renal tubular acidosis
Endogenous or exogenous osmotic diuretic
* Diuretic therapy
Carbenicillin, penicillin therapy
Leukemias
Potassium deficit without
hypokalemia
Acid-base disturbance
Uremia
Congestive heart failure
Approach
to the hypokalemia patient:
1) Is there an internal shift of potassium?
Look for alkalemia, excessive
insulin activity (glucose or, insulin infusion), excessive beta agonist
activity (isoproterenol administration), unusual disorders such as periodic
paralysis (thyrotoxicosis).
2) Is there excessive gastrointestinal loss of
potassium?
Look for diarrhea, vomiting,
laxative use.
3) Is there excessive renal loss of potassium?
Look for diuretic use and the more
uncommon things listed in the table.
4) Is there excessive sweating?
5) Is there a very low potassium intake?
Another approach is to think of the
renal response to a potassium deficit (slow decrease in K+
excretion) and the effect of acid-base disorders on K+ (internal
shifts, renal K+ losses with metabolic alkalosis). Thus excessive lower gastrointestinal K+
losses leading to chronic hypokalemia should cause renal K+
excretion to fall.
3. Treatment of Hypokalemia/Potassium Deficiency
The goal of treatment is to restore
plasma and total body K+ to normal.
In an emergency such as a cardiac arrhythmia or paralysis, potassium
must be given intravenously with caution.
Generally oral supplements are preferable when feasible. Supplementation of the diet with potassium
rich foods should also be done when feasible.
Diuretics that reduce renal K+ excretion may be useful at
times (spironolactone, trimterene, amiloride) depending on the clinical
situation.
HYPERKALEMIA
Hyperkalemia is less common than
hypokalemia but may be more dangerous.
Plasma (or serum) levels above 7.0 mmol/L seriously derang organ
function and levels above 8-10 mmol/L are often fatal.
1. Consequence of Hyperkalemia
a.
Cardiac Effects
An acute rise in plasma K+
reduces the ratio of Ki/Ko which raises cell membrane potential toward the
threshold potential. The ECG effects of
hyperkalemia are demonstrated in the following figure.

Figure
5. EKG changes associated with hyperkaliemia:
-
ca.
6 mEq/l increased amplitude of T wave with shortened Q-T interval
-
ca.
7-8 mEq/l widening of QRS complex, decreased amplitude of P wave with eventunal
loss of P wave
-
following
these changes ventricular fibrillation, cardiac standstill
b.
Neuromuscular Effects
These resemble the changes in
hypokalemia but are due to depolarization, not hyperpolarization. Thus weakness progressing to paralysis may
occur.
2. Causes of Hyperkalemia
Pseudohyperkalemia
Tourniquet
method of drawing blood
Hemolysis
of drawn blood
Increased
WBC or platelet count ()
The table contains a detailed listing of the causes of
hyperkalemia. Of note is the
occurrence of pseudohyperkalemia.
Use of a syringe with heparin as the anticoagulant and avoidance of
a tourniquet will avoid the generation of a technical elevation of
potassium concentration. Again the
use of the balance will allow rational analysis.
True
hyperkalemia
Redistribution
Acidosis
Hyperkalemic
familial periodic paralysis
Digitalis
intoxication
Beta
adrenergic blockade
Decreased excretion
Chronic
or acute renal failure
Hyporeninemic
hypoaldosteronism
Selective
renal impairment of potassium excretion
Systemic
lupus erthematosis
Renal
allograft
Sickle
cell disease
Increased input
Endogenous input
Hemolysis
Rhabdomyolysis
Exogenous
input
Salt
substitutes
Potassium
penicillin
Approach to the hyperkalemic patient:
1)
Is this true hyperkalemia?
2) Is
there an internal shift of K+ into the ECF?
Look
for academia, massive digits intoxication , adrenergic blockade, tissue injury.
3) Is
there decreased renal potassium excretion?
Look
for severe renal failure (GFR below 10 ml/min), hypoaldosteronism, K+, sparing
diuretics.
4) Is
there a major increase in K+ input?
Look
for IV infusion faster than 40 mEq/h, dietary intake greater than 300 mEq. If renal failure is present, look for use of
“salt substitute” which KCl.
3.
Treatment of Hyperkalemia
Treatment
of serious hyperkalemia is based on reversing physiological problems. The following table describes the principles
and types of treatment.
|
Principal |
Treatment |
Onset |
Duration |
|
Reversible Depolarization |
Calcium infusion |
1-3 minutes |
30-60 minutes |
|
Shift K+ into cells |
Insulin |
15-30 minutes |
12-24 hours |
|
|
NaHCO3 infusion |
15-60 minutes |
12-24 hours |
|
|
Beta agonst |
30 minutes |
2-4 hours |
|
Remove K+ from body |
Kayexelate |
1-2 hours |
4-6 hours |
|
|
(Ion exchange resin by mouth) |
|
|
|
|
Diuretics (furosemide) |
Start of Diuresis |
End of Diuresis |
|
|
Hemodialysis |
Rapid |
Duration of dialysis |